Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
Journal of Clinical and Translational Hepatology
|
August 14, 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
Xavier Adhoute, Olivia Pietri, Guillaume Pénaranda, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2018
Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice
Cynthia Lebeaupin, Déborah Vallée, Déborah Rousseau, et al.
Journal of Hepatology
|
July 24, 2012
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
Rodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
Journal of Hepatology
|
January 18, 2011
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
Esther Zimmermann, Rodolphe Anty, Joan Tordjman, et al.
Journal of Hepatology
|
March 22, 2017
CD44 is a key player in non-alcoholic steatohepatitis
Stéphanie Patouraux, Déborah Rousseau, Stéphanie Bonnafous, et al.
The American Journal of Gastroenterology
|
June 23, 2006
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH
Rodolphe Anty, Soumeya Bekri, Nathalie Luciani, et al.
JHEP Reports : Innovation in Hepatology
|
May 1, 2023
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
François Villeret, Fanny Lebossé, Sylvie Radenne, et al.
Scientific Reports
|
May 18, 2019
The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
Arnaud Sans, Stéphanie Bonnafous, Déborah Rousseau, et al.
Diabetes & Metabolism
|
August 7, 2021
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
Jerome Boursier, Rodolphe Anty, Claire Carette, et al.
JHEP Reports : Innovation in Hepatology
|
February 9, 2026
Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis
Lucy Meunier, Clement Monet, Antonio Saviano, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
Journal of Clinical and Translational Hepatology
|
August 14, 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
Xavier Adhoute, Olivia Pietri, Guillaume Pénaranda, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2018
Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice
Cynthia Lebeaupin, Déborah Vallée, Déborah Rousseau, et al.
Journal of Hepatology
|
July 24, 2012
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
Rodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
Journal of Hepatology
|
January 18, 2011
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
Esther Zimmermann, Rodolphe Anty, Joan Tordjman, et al.
Journal of Hepatology
|
March 22, 2017
CD44 is a key player in non-alcoholic steatohepatitis
Stéphanie Patouraux, Déborah Rousseau, Stéphanie Bonnafous, et al.
The American Journal of Gastroenterology
|
June 23, 2006
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH
Rodolphe Anty, Soumeya Bekri, Nathalie Luciani, et al.
JHEP Reports : Innovation in Hepatology
|
May 1, 2023
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
François Villeret, Fanny Lebossé, Sylvie Radenne, et al.
Scientific Reports
|
May 18, 2019
The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
Arnaud Sans, Stéphanie Bonnafous, Déborah Rousseau, et al.
Diabetes & Metabolism
|
August 7, 2021
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
Jerome Boursier, Rodolphe Anty, Claire Carette, et al.
JHEP Reports : Innovation in Hepatology
|
February 9, 2026
Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis
Lucy Meunier, Clement Monet, Antonio Saviano, et al.
Page
of 14